Printer Friendly
The Free Library
4,536,868 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ADVISORY/SCOLR, Inc. Presentation at American Stock Exchange Annual Online Healthcare & Biotech Investor Conference.


WHAT: SCOLR, Inc. (Amex:DDD) Presentation at the American Stock
      Exchange and Amex Online Alliance Online Conference

WHEN: June 22, 2004 at 12:30 PM EDT

WHERE: http://www.vcall.com/CEPage.asp?ID=88411

HOW: Live over the Internet --- simply log on to the web address
     above.

CONTACT: Terri MacInnis, Dir. Of I.R., 818-379-8500
         terrimac@pacbell.net



If you are unable to participate during the live webcast, the presentation will be archived at www.vcallconferences.com.

Based in Bellevue, Washington, SCOLR, Inc. is a specialty pharmaceutical company leveraging formulation expertise and its patented CDT(R) platform to introduce distinctive and novel OTC products, prescription drugs and dietary supplements. SCOLR's CDT drug delivery platform provides distinctive products with tangible benefits for the consumer and competitive commercial advantages for licensees. For more information on SCOLR, please call 425.373.0171 or visit http://www.SCOLR.com/.

For a complete agenda of the American Stock Exchange
American Stock Exchange (AMEX)
Stock exchange with the third highest volume of trading in the US. Located at 86 Trinity Place in downtown Manhattan. The bulk of trading on AMEX consists of index options (computer technology index, institutional index, major market index) and shares of small to medium-sized companies are predominant. Recently merged with Nasdaq See: Curb.
 and Amex IR Alliance Online Conference, please visit http://www.vcallconferences.com/conferences/AMEX/0622-29-2004/index.as p?ID=88206.

About American Stock Exchange: The American Stock Exchange(R) (Amex(R)) is the only primary exchange that offers trading across a full range of equities, options and exchange traded funds (ETFs), including structured products and HOLDRS(SM). In addition to its role as a national equities market, the Amex is the pioneer of the ETF, responsible for bringing the first domestic product to market in 1993. Leading the industry in ETF listings, the Amex lists 138 ETFs to date. The Amex is also one of the largest options exchanges in the U.S., trading options on broad-based and sector indexes as well as domestic and foreign stocks.

Minimum requirements to listen to broadcast: Windows Media Player software, downloadable free from http://microsoft.com/windows/windowsmedia/EN/default.asp and at least a 28.8Kbps connection to the Internet. If you experience problems listening to the broadcast, please send an email to webmaster@vcall.com.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jun 21, 2004
Words:329
Previous Article:Fitch Rates $200MM Emigrant Bancorp Senior Notes 'BBB+'.
Next Article:Washington Group-Led Joint Venture Wins $600.4 Million Contract to Design and Build Six-Mile-Long Light Rail Extension in Los Angeles.
Topics:



Related Articles
ATC Healthcare Invites You to Join Its Webcast At the American Stock Exchange Online Conference.
SCOLR, Inc. Applies for Listing on the American Stock Exchange.
SCOLR, Inc. Approved for Listing on American Stock Exchange.
Cortex Pharmaceuticals to Present at American Stock Exchange Annual Online Healthcare & Biotech Investor Conference.
Medicure to Present at American Stock Exchange Online Healthcare and Biotech Investor Conference.
SCOLR Pharma to Present at Rodman & Renshaw Healthcare Conference in New York City.
SCOLR Pharma to Present at Rodman & Renshaw Healthcare Conference in New York City.
SCOLR Pharma to Present at the American Stock Exchange's First Annual Healthcare Investor Conference.
CytRx creates subsidiary for gene-silencing technology: RXi will focus on RNAi interference for treatment of diseases.(DEVELOPMENT)
BioSante Pharmaceuticals to Present at Upcoming Conferences.

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles